Taikang BioPharmaceutical Co. will start selling chitosan wound powder

The company, located in Tianjin, has developed an instant analgesic chitosan wound powder for military use and will now start commercialization in the civilian domain. The product is either obtained by high-pressure extraction of Aspergillus niger from citric acid fermentation, followed by purification, or from shellfish chitin.

China Industrial Biotechnology Network, march 20, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny